USPTO serial 86235689
TAIHO ONCOLOGY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 31, 2015
- Examiner
- DELANEY, ZHALEH SYBIL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with TAIHO ONCOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Taiho Pharmaceutical Co., Ltd.
Tokyo, 101-8444, JP
Taiho Pharmaceutical Co., Ltd.
Tokyo, 101-8444, JP
Taiho Pharmaceutical Co., Ltd.
Tokyo, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Lim
Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 West 42nd Street, 17th FloorNEW YORK, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, anti-cancer agents, anti-tumor agents, [ anti-ulcerogenic agents, agents for treatment of immunological diseases, agents for the treatment of urinary diseases, agents for pain, antiemetic agents, diagnostic agents, ] preparations and substances for medical purposes [, preparations for detecting genetic predispositions for medical purposes ] | ACTIVE | — |
| 042 | Scientific research for medical purposes in the field of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; testing, inspection, research or evaluation of pharmaceuticals; [ advisory, consultancy or information services relating to testing, inspection, research or evaluation of pharmaceuticals and medicines; ] providing medical and scientific research information about the results of clinical trials for pharmaceutical products [ ; design and development of computer hardware and software for use in the field of medicine; research and development of medical technology ] | ACTIVE | — |
| 044 | Medical diagnostic testing in the fields of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; providing medical information relating to the treatment or prevention of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; medical consultation services relating to the treatment and diagnosis of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; medical counseling services relating to the treatment of cancer, tumors [ , ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ; genetic testing for medical purposes, namely, for the diagnosis and prognosis of the expected progression of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ; providing medical information relating to efficacy, side effects, and interactions of pharmaceuticals and medications ] ; providing medical information | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Taiho Pharmaceutical Co., Ltd.
- Other trademarks owned by Taiho Pharmaceutical Co., Ltd.
- Other trademarks owned by Taiho Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TAIHO ONCOLOGY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 26, 2025 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Jul 26, 2025 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Jul 26, 2025 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Jul 26, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 5, 2025 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 31, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Apr 7, 2022 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Apr 7, 2022 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Mar 29, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 10, 2021 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Apr 5, 2017 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | — |
| Jan 31, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 13, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 24, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 5, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 1, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 25, 2014 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Nov 24, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 24, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 20, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 20, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 19, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 2, 2014 | CPRA | PRIORITY ACTION MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 2, 2014 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 30, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 25, 2014 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Apr 25, 2014 | ALIE | ASSIGNED TO LIE | — |
| Apr 12, 2014 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Apr 11, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 4, 2014 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 1, 2014 | NWAP | NEW APPLICATION ENTERED | — |